Health Care & Life Sciences » Pharmaceuticals | CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc. | Mutual Funds

Mutual Funds that own CASI Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
iShares Russell 2000 ETF
1,044,403
1.21%
-558
0.02%
09/06/2018
Vanguard Total Stock Market Index Fund
874,637
1.01%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
604,372
0.7%
2,624
0.01%
07/31/2018
iShares Russell 2000 Growth ETF
443,242
0.51%
0
0.03%
09/06/2018
Fidelity Spartan Extended Market Index Fund
202,276
0.23%
0
0.01%
07/31/2018
ALPS Medical Breakthroughs ETF
156,965
0.18%
0
0.38%
09/07/2018
iShares Micro Cap ETF
133,898
0.16%
0
0.08%
09/06/2018
Royce Value Plus Fund
120,000
0.14%
120,000
0.21%
06/30/2018
100,000
0.12%
-243,500
8.63%
06/30/2018
Schwab Small Cap Index Fund
93,000
0.11%
93,000
0.02%
06/30/2018

About CASI Pharmaceuticals

View Profile
Address
9620 Medical Center Drive
Rockville Maryland 20850
United States
Employees -
Website http://www.casipharmaceuticals.com
Updated 07/08/2019
CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs with commercial focus on the China market. The firm develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau. The drugs are Captisol-Enabled, ZEVALIN and MARQIBO.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.